Zomedica Corp.
ZOMDF
$0.05
$0.014540.85%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.24% | 1.84% | 14.23% | 19.17% | 32.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.24% | 1.84% | 14.23% | 19.17% | 32.89% |
| Cost of Revenue | -2.42% | -10.29% | 30.24% | 16.34% | 56.92% |
| Gross Profit | 16.00% | 7.76% | 7.35% | 20.47% | 24.24% |
| SG&A Expenses | 12.83% | 19.82% | 22.08% | 54.41% | 6.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.42% | 18.90% | 28.12% | 65.82% | 8.15% |
| Operating Income | -25.08% | -34.13% | -38.26% | -121.75% | 9.77% |
| Income Before Tax | -178.89% | -352.01% | -50.98% | -468.87% | 57.34% |
| Income Tax Expenses | 98.59% | -85.71% | -179.81% | 143.76% | -192.24% |
| Earnings from Continuing Operations | -1,263.95% | -355.92% | -43.46% | -697.65% | 90.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,263.95% | -355.92% | -43.46% | -697.65% | 90.17% |
| EBIT | -25.08% | -34.13% | -38.26% | -121.75% | 9.77% |
| EBITDA | -24.36% | -34.00% | -37.50% | -143.83% | 19.97% |
| EPS Basic | -1,260.00% | -351.85% | -43.08% | -689.66% | 90.20% |
| Normalized Basic EPS | -44.83% | -50.00% | -53.85% | -164.00% | 19.44% |
| EPS Diluted | -1,260.00% | -351.85% | -43.08% | -689.66% | 90.20% |
| Normalized Diluted EPS | -44.83% | -50.00% | -53.85% | -164.00% | 19.44% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
